Switch theme
Sign up to access all valuation multiples
Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm’s wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm’s salesforce or directly to consumers (such as Byte clear aligner).
1983
14K+
LTM Revenue $3.7B
LTM EBITDA $669M
$5.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dentsply Sirona has a last 12-month revenue (LTM) of $3.7B and a last 12-month EBITDA of $669M.
In the most recent fiscal year, Dentsply Sirona achieved revenue of $3.8B and an EBITDA of -$518M.
Dentsply Sirona expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dentsply Sirona valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | XXX | $3.8B | XXX | XXX | XXX |
| Gross Profit | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| Gross Margin | 54% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $669M | XXX | -$518M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | -14% | XXX | XXX | XXX |
| EBIT | $522M | XXX | $188M | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $362M | XXX | -$910M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | -24% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 14, 2025, Dentsply Sirona's stock price is $16.
Dentsply Sirona has current market cap of $3.2B, and EV of $5.3B.
See Dentsply Sirona trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.3B | $3.2B | XXX | XXX | XXX | XXX | $1.79 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 14, 2025, Dentsply Sirona has market cap of $3.2B and EV of $5.3B.
Dentsply Sirona's trades at 1.4x EV/Revenue multiple, and -10.1x EV/EBITDA.
Equity research analysts estimate Dentsply Sirona's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dentsply Sirona has a P/E ratio of 8.9x.
See valuation multiples for Dentsply Sirona and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.2B | XXX | $3.2B | XXX | XXX | XXX |
| EV (current) | $5.3B | XXX | $5.3B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 7.9x | XXX | -10.1x | XXX | XXX | XXX |
| EV/EBIT | 10.1x | XXX | 28.0x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 8.9x | XXX | -3.6x | XXX | XXX | XXX |
| EV/FCF | 22.3x | XXX | 18.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDentsply Sirona's last 12 month revenue growth is -1%
Dentsply Sirona's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Dentsply Sirona's rule of 40 is 6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dentsply Sirona's rule of X is 17% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Dentsply Sirona and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -1% | XXX | -1% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | -14% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 68% | XXX | XXX | XXX |
| Rule of 40 | 6% | XXX | -14% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dentsply Sirona acquired XXX companies to date.
Last acquisition by Dentsply Sirona was XXXXXXXX, XXXXX XXXXX XXXXXX . Dentsply Sirona acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Dentsply Sirona founded? | Dentsply Sirona was founded in 1983. |
| Where is Dentsply Sirona headquartered? | Dentsply Sirona is headquartered in United States of America. |
| How many employees does Dentsply Sirona have? | As of today, Dentsply Sirona has 14K+ employees. |
| Who is the CEO of Dentsply Sirona? | Dentsply Sirona's CEO is Mr. Simon D. Campion. |
| Is Dentsply Sirona publicy listed? | Yes, Dentsply Sirona is a public company listed on NAS. |
| What is the stock symbol of Dentsply Sirona? | Dentsply Sirona trades under XRAY ticker. |
| When did Dentsply Sirona go public? | Dentsply Sirona went public in 1983. |
| Who are competitors of Dentsply Sirona? | Similar companies to Dentsply Sirona include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Dentsply Sirona? | Dentsply Sirona's current market cap is $3.2B |
| What is the current revenue of Dentsply Sirona? | Dentsply Sirona's last 12 months revenue is $3.7B. |
| What is the current revenue growth of Dentsply Sirona? | Dentsply Sirona revenue growth (NTM/LTM) is -1%. |
| What is the current EV/Revenue multiple of Dentsply Sirona? | Current revenue multiple of Dentsply Sirona is 1.4x. |
| Is Dentsply Sirona profitable? | Yes, Dentsply Sirona is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dentsply Sirona? | Dentsply Sirona's last 12 months EBITDA is $669M. |
| What is Dentsply Sirona's EBITDA margin? | Dentsply Sirona's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Dentsply Sirona? | Current EBITDA multiple of Dentsply Sirona is 7.9x. |
| What is the current FCF of Dentsply Sirona? | Dentsply Sirona's last 12 months FCF is $236M. |
| What is Dentsply Sirona's FCF margin? | Dentsply Sirona's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Dentsply Sirona? | Current FCF multiple of Dentsply Sirona is 22.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
